Survival of Preventive Care Coverage Mandate Would Boost Some Health Care Firms

  • Apr 25, 2025

    Although health insurers don’t have much to lose in a Supreme Court case concerning free preventive care coverage, certain diagnostics companies and pharmaceutical firms are very invested in the outcome. Those firms — and their investors — received a welcome surprise on April 21 when oral arguments in the case known as Kennedy v. Braidwood suggested that the high court will protect one of the Affordable Care Act’s key provisions. 

    “The court surprisingly seems likely to uphold the constitutionality of the task force, including the appointment of task force members and the supervision by the HHS secretary,” Richard Hughes IV, a health care lawyer at Epstein Becker Green, wrote in an email to clients, reporters and other stakeholders after attending the oral arguments.  

    Read more
    © 2025 MMIT
  • Leslie Small

    Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

The Latest
Meet Our Reporters

Meet Our Reporters

×